| Dr James Timothy Foote, MD | |
|
1001 Noble St, Fairbanks, AK 99701-4922 | |
| (907) 459-3520 | |
| (907) 459-3554 |
| Full Name | Dr James Timothy Foote |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 44 Years |
| Location | 1001 Noble St, Fairbanks, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033184023 | NPI | - | NPPES |
| 1020064 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 2059 (Alaska) | Secondary |
| 207K00000X | Allergy & Immunology | 2059 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanana Valley Clinic Llc | 5698056901 | 105 |
News Archive
Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
More than 150,000 additional Americans could die by the end of this century due to excessive heat caused by climate change, according to a detailed analysis of peer-reviewed scientific data by the Natural Resources Defense Council.
AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS nonprofit medical provider, today expressed its disappointment and dismay at the Food and Drug Administration's (FDA) decision to grant an expedited review for Gilead Sciences' application for expanded use of its blockbuster AIDS drug, Truvada, as a means of preventing HIV infection in non-infected people.
Today, invasive animals and plants spread all around the globe. Predicting the dynamics of these invasions is of great ecological and socioeconomical interest. Yet studying them is fundamentally challenging because of the large spatial and temporal scales involved. Scientists at Eawag and University of Zurich are now using computer simulations and small artificial laboratory worlds, to study how rapid evolution makes invaders spread even faster.
› Verified 2 days ago
| Entity Name | Tanana Valley Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922559558 PECOS PAC ID: 5698056901 Enrollment ID: O20161228001991 |
News Archive
Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
More than 150,000 additional Americans could die by the end of this century due to excessive heat caused by climate change, according to a detailed analysis of peer-reviewed scientific data by the Natural Resources Defense Council.
AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS nonprofit medical provider, today expressed its disappointment and dismay at the Food and Drug Administration's (FDA) decision to grant an expedited review for Gilead Sciences' application for expanded use of its blockbuster AIDS drug, Truvada, as a means of preventing HIV infection in non-infected people.
Today, invasive animals and plants spread all around the globe. Predicting the dynamics of these invasions is of great ecological and socioeconomical interest. Yet studying them is fundamentally challenging because of the large spatial and temporal scales involved. Scientists at Eawag and University of Zurich are now using computer simulations and small artificial laboratory worlds, to study how rapid evolution makes invaders spread even faster.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Timothy Foote, MD 1001 Noble St, Fairbanks, AK 99701-4922 Ph: (907) 459-3500 | Dr James Timothy Foote, MD 1001 Noble St, Fairbanks, AK 99701-4922 Ph: (907) 459-3520 |
News Archive
Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
More than 150,000 additional Americans could die by the end of this century due to excessive heat caused by climate change, according to a detailed analysis of peer-reviewed scientific data by the Natural Resources Defense Council.
AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS nonprofit medical provider, today expressed its disappointment and dismay at the Food and Drug Administration's (FDA) decision to grant an expedited review for Gilead Sciences' application for expanded use of its blockbuster AIDS drug, Truvada, as a means of preventing HIV infection in non-infected people.
Today, invasive animals and plants spread all around the globe. Predicting the dynamics of these invasions is of great ecological and socioeconomical interest. Yet studying them is fundamentally challenging because of the large spatial and temporal scales involved. Scientists at Eawag and University of Zurich are now using computer simulations and small artificial laboratory worlds, to study how rapid evolution makes invaders spread even faster.
› Verified 2 days ago
Anthony J Bonitatibus, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1001 Noble St Ste 1, Fairbanks, AK 99701 Phone: 907-458-2635 |